"Cipla and its subsidiary Cipla USA, Inc announce the launch of Daptomycin for Injection, 500mg/vial, single-dose vial, AP-rated generic equivalent of Cubicin for Injection in the US," the company said.
from India Infoline News Service https://ift.tt/2lG7GfU
No comments:
Post a Comment